Phibro Animal Health Corporation Class A Common Stock (PAHC)
Stock · NASDAQ · Health Care
$38.82as of 10/16/2026
Price chart
Active signals
PAHC Signal Track Record
How signals performed across all stocks →What PAHC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | +3.6% | 58% | September 18, 2026 |
| Bollinger Band Breakout | 23 | +1.2% | 52% | August 28, 2026 |
| Bollinger Band Breakdown | 19 | +1.2% | 53% | May 7, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -3.9% | 45% | May 7, 2026 |
| Any 20-session window (baseline) | +1.9% | 57% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PAHC
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef an…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 2,605
- Website
- www.pahc.com/
Fundamentals
- 1-day range
- $37.24$38.72
- Market cap
- $1.44B
- P/E (trailing)
- 15.44
- P/E (forward)
- 10.06
- EPS (trailing)
- $2.43
- Dividend yield
- 4.55%
- Beta
- 0.43
- Avg. volume
- 227.7K
- Ex-dividend date
- September 2, 2026
- Dividend pay date
- September 23, 2026
How Phibro Animal Health Corporation Class A Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Aug 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Phibro Animal Health Corporation Class A Common Stock Competitors
Chosen by industry and closest market cap.
- PAHCPhibro Animal Health Corporation Class A Common Stock$38.82▲ 2.21%Market cap $1.44BP/E 15.44$28.25$60.08
- AVBPArriVent BioPharma Inc. Common Stock$16.66▼ 0.77%Market cap $1.44BP/E —$11.36$35.83
- XNCRXencor Inc. Common Stock$22.85▼ 4.79%Market cap $1.48BP/E —$10.38$30.61
- HROWHarrow Inc. Common Stock$27.28▼ 5.11%Market cap $1.49BP/E —$26.96$54.85
- LBRXLB Pharmaceuticals Inc Common Stock$36.74▲ 0.14%Market cap $1.38BP/E —$14.32$50.16
- ORICOric Pharmaceuticals Inc. Common Stock$12.35▼ 3.29%Market cap $1.34BP/E —$7.23$14.68
- SDGRSchrodinger Inc. Common Stock$22.6▼ 11.30%Market cap $1.33BP/E —$10.95$33.78
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PAHC Phibro Animal Health Corporation Class A Common Stock | $1.44B | 15.44 | $38.82 | ▲ 2.21% | $28.25$60.08 |
| AVBP ArriVent BioPharma Inc. Common Stock | $1.44B | — | $16.66 | ▼ 0.77% | $11.36$35.83 |
| XNCR Xencor Inc. Common Stock | $1.48B | — | $22.85 | ▼ 4.79% | $10.38$30.61 |
| HROW Harrow Inc. Common Stock | $1.49B | — | $27.28 | ▼ 5.11% | $26.96$54.85 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.38B | — | $36.74 | ▲ 0.14% | $14.32$50.16 |
| ORIC Oric Pharmaceuticals Inc. Common Stock | $1.34B | — | $12.35 | ▼ 3.29% | $7.23$14.68 |
| SDGR Schrodinger Inc. Common Stock | $1.33B | — | $22.6 | ▼ 11.30% | $10.95$33.78 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 3 Small-Cap Stocks with Warning SignsYahoo · 10/9/2026
- Is it the Right Time to Hold TNDM Stock in Your Portfolio?Yahoo · 10/9/2026
- What Is Drawing Attention To Phibro Animal Health (PAHC) Today?Yahoo · 10/9/2026
- Is it the Right Time to Add Phibro Stock to Your Portfolio?Yahoo · 10/8/2026
- Teladoc Strengthens Solo Platform With New AI-Powered Care ToolsYahoo · 10/8/2026
- Encompass Health Expands Rehab Footprint With New Maine HospitalYahoo · 10/7/2026
- Is This the Right Time to Add TMO Stock to Your Portfolio?Yahoo · 10/7/2026
- PAHC vs. HAE: Which Stock Is the Better Value Option?Yahoo · 10/5/2026
Insider Activity
Insider Actions →- David Glenn · August 6, 2026 · Grant3.5K
- Miller Larry Lee · August 6, 2026 · Grant3.7K
- Rodriguez Patrick · August 6, 2026 · Grant1.5K
- David Glenn · August 6, 2026 · Grant3.3K
- Miller Larry Lee · August 6, 2026 · Grant3.5K
- Escudero Lisa Ann · August 6, 2026 · Grant1.5K
- BENDHEIM Jonathan · August 6, 2026 · Grant2.7K
- Weinstein Judith · August 6, 2026 · Grant2.5K
- BENDHEIM JACK · August 6, 2026 · Grant12.1K
- Bendheim Daniel M · August 6, 2026 · Grant11.7K
- BENDHEIM JACK · August 4, 2026 · J2.3K @ $36.6
- Escudero Lisa Ann · August 4, 2026 · J265 @ $36.6
- Miller Larry Lee · August 4, 2026 · J635 @ $36.6
- Weinstein Judith · August 4, 2026 · J472 @ $36.6
- David Glenn · August 4, 2026 · J840 @ $36.6
Institutional Ownership
March 31, 2026
- Total shares held
- 19.46M
- Total value held
- $995.09M
- Institutional holders
- 251
- Unknown3.25M
- Unknown2.17M
- Unknown950.0K
- Unknown891.3K
- Unknown617.1K
- Unknown604.6K
- Unknown576.7K
- Unknown507.9K
- Unknown455.9K
- Unknown397.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Phibro Animal Health (PAHC) Draws Attention Amid Small-Cap Review
Phibro Animal Health (PAHC) is currently the focus of market attention, with recent articles discussing whether it is the right time to hold the stock. The company is also highlighted in a list of small-cap stocks showing warning signs. This news provides context for the stock's current position within its 52-week range, which spans from $28.25 to $60.08.
Phibro Animal Health (PAHC) Draws Attention Amid Small-Cap Review. Phibro Animal Health (PAHC) is currently the focus of market attention, with recent articles discussing whether it is the right time to hold the stock. The company is also highlighted in a list of small-cap stocks showing warning signs. This news provides context for the stock's current position within its 52-week range, which spans from $28.25 to $60.08.